SDHB and cancer: This leads to the complete impairment of SDH activity and dysfunction of the TCA cycle in transformed cells, resulting in the consequent accumulation of succinate, an oncometabolite reprogramming gene expression in cancer by activating hypoxia-inducible factors and inhibiting α-ketoglutarate-dependent histone and DNA demethylases [17–19].